Deprescribing Guidelines: Special Section on Symposium Results. | AHRQ Patient Safety Network

Deprescribing Guidelines: Special Section on Symposium Results. | AHRQ Patient Safety Network

• Special or Theme Issue
 
• Published June 2019

Deprescribing Guidelines: Special Section on Symposium Results.

Res Social Adm Pharm. 2019;15:780-810.

Appropriate deprescribing can reduce the risks associated with polypharmacy, overuse, and accidental overdose. Articles in this special issue cover findings from a symposium discussing guidelines for safe discontinuation of medications and research needed to support further understanding of deprescribing practices.

PubMed citationsTable of contents

Related Resources

LEGISLATION/REGULATION › ORGANIZATIONAL POLICY/GUIDELINES

ASHP guidelines on preventing medication errors in hospitals.

Billstein-Leber M, Carrillo CJD, Cassano AT, Moline K, Robertson JJ. Am J Health Syst Pharm. 2018;75:1493-1517.

JOURNAL ARTICLE › COMMENTARY

Developing a principle-based approach to safe medication practices.

Hallaran A, McNabb A, Anderson J. J Nurs Reg. 2015;6:43-47.

WEB RESOURCE › MULTI-USE WEBSITE

The Institute for Safe Medication Practices.

200 Lakeside Drive, Suite 200; Horsham, PA 19044.

JOURNAL ARTICLE › STUDY

Opioid medication discontinuation and risk of adverse opioid-related health care events.

Mark TL, Parish W. J Subst Abuse Treat. 2019 May 5; [Epub ahead of print].

JOURNAL ARTICLE › COMMENTARY

Limits on opioid prescribing leave patients with chronic pain vulnerable.

Rubin R. JAMA. 2019 Apr 29; [Epub ahead of print].

View More